(Q63832954)
Statements
Pharmacokinetics, Safety and Tolerability of BI 10773 50 mg Single Dose in Male and Female Subjects With Different Degrees of Liver Impairment (Child-Pugh Classification A, B and C) as Compared to Male and Female Healthy Subjects (a Non-blinded, Parallel Group Study of Phase I) (English)
0 references
July 2010
0 references
November 2010
0 references
36
0 references
18 year
0 references
75 year
0 references